The ailment is usually preceded by a premalignant condition (MBL) which shares most molecular drivers with overt CLL. In lots of scenarios, these molecular motorists keep on being continuous with time. On the other hand, clonal evolution is also feasible and is often connected to exponential tumor advancement, progressive sickness and, occasionally